Form4insider filings, from the source

SEC Form 4 · accession 0001567619-18-003541

Gritstone Oncology, Inc. · GRTS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas Woiwode
Director · 10% Owner
Period of report
Oct 2, 2018
Accepted (ET)
Oct 2, 2018 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001656634

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Oct 2, 2018C3,102,929—A3,102,929ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF4,F1—Oct 2, 2018C2,173,909D——Common Stock2,173,9090I
Series B Convertible Preferred StockF5,F2—Oct 2, 2018C929,020D——Common Stock929,0200I

Explanation of responses